Latest Quarterly Reports News

Fitzroy River Corporation's latest quarterly report reveals a dip in royalty income but highlights progress on major silver and gold projects, alongside strategic moves in energy royalties.

Leeuwin Metals has inked a binding deal to acquire the Marda Gold Project from Ramelius Resources, marking a strategic expansion into Western Australia's prolific goldfields. Alongside promising iron ore results from its West Pilbara project, Leeuwin is positioning itself as a diversified explorer with significant growth potential.

Killi Resources reports compelling drill results from its Kaa gold-copper prospect in Queensland, confirming a large mineralised system and maintaining a strong cash position of $2.03 million to fund ongoing exploration.

Terramin's December 2024 quarterly report reveals major progress at its Tala Hamza Zinc Project with land acquisition and a $336 million EPC contract, while the Bird in Hand Gold Project faces a legal hurdle after the Supreme Court dismissed its mining lease application.

Sprintex has locked in A$30 million in distribution agreements across the UK, Turkiye, and India, while advancing its innovative G25 Jet Blower launch, signaling a strong growth trajectory in energy-efficient technologies.

Argosy Minerals has reported significant progress on its flagship Rincon Lithium Project, including an upgraded mineral resource estimate and advancing engineering and feasibility studies toward a 12,000tpa lithium carbonate operation.

Brockman Mining Limited's latest quarterly report reveals steady progress on the Marillana Project, underpinned by joint ventures with Mineral Resources and Hancock Prospecting, alongside key infrastructure developments at Port Hedland.

Sagalio Energy reported stable production of 510 tons of oil and sales revenue of nearly US$124,000 for the December 2024 quarter, navigating slight price volatility while expanding output modestly.

VDM Group Limited faces a complex ownership dispute over its Angolan projects, leading to halted exploration and a prolonged ASX trading suspension. Meanwhile, the company is actively pursuing new critical minerals opportunities in Australia to revive its operations.

InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.

Global Masters Fund Limited's latest quarterly report confirms compliance with all financial obligations and highlights a recent interest rate increase on its convertible notes, supported by a robust loan-to-value ratio.

Flagship Investments Limited has released its quarterly report confirming a stable loan-to-value ratio of 19.77% and full compliance with regulatory requirements for the period ending December 2024.